These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12681440)

  • 21. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
    J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
    J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
    Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation.
    Wang Y; Wu YP; Han JJ; Zhang MQ; Yang CX; Jiao P; Tian H; Zhu C; Qin SC; Sun XJ; Zhang HT; Zhao XM
    Life Sci; 2019 Sep; 233():116700. PubMed ID: 31356907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
    Collen D; Lu HR; Stassen JM; Vreys I; Yasuda T; Bunting S; Gold HK
    Thromb Haemost; 1994 Jan; 71(1):95-102. PubMed ID: 8165652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo effect of a thrombin-like enzyme on platelet plug formation induced in mesenteric microvessels of mice.
    Chang MC; Huang TF
    Thromb Res; 1994 Jan; 73(1):31-8. PubMed ID: 8178311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
    Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
    Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
    Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
    Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of free radical generation in platelets and primary hepatocytes: A novel electron spin resonance study.
    Wang CL; Yang PS; Tsao JT; Jayakumar T; Wang MJ; Sheu JR; Chou DS
    Mol Med Rep; 2018 Jan; 17(1):2061-2069. PubMed ID: 29138834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced nicotinamide adenine dinucleotide phosphate inhibits rat platelet aggregation and p38 phosphorylation.
    Gu Y; Sheng R; Wu J; Zhou Y; Qin ZH
    Thromb Res; 2018 Nov; 171():121-129. PubMed ID: 30292134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo.
    Yamashita T; Shoge M; Oda E; Yamamoto Y; Giddings JC; Kashiwagi S; Suematsu M; Yamamoto J
    Platelets; 2006 May; 17(3):201-6. PubMed ID: 16702048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase Cgamma2-protein kinase C pathway in platelet activation.
    Shen MY; Hsiao G; Fong TH; Chou DS; Sheu JR
    Pharmacol Res; 2008 Feb; 57(2):151-8. PubMed ID: 18313326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
    Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
    Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative.
    Yuk DY; Lee HY; Ryu CK; Hong JT; Kang WS; Yoo HS; Yun YP
    Arzneimittelforschung; 2000 Mar; 50(3):254-9. PubMed ID: 10758777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.